129 related articles for article (PubMed ID: 11684956)
1. P504S: a new molecular marker for the detection of prostate carcinoma.
Jiang Z; Woda BA; Rock KL; Xu Y; Savas L; Khan A; Pihan G; Cai F; Babcook JS; Rathanaswami P; Reed SG; Xu J; Fanger GR
Am J Surg Pathol; 2001 Nov; 25(11):1397-404. PubMed ID: 11684956
[TBL] [Abstract][Full Text] [Related]
2. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
4. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
5. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
Vanguri VK; Woda BA; Jiang Z
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
[TBL] [Abstract][Full Text] [Related]
8. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
Jiang Z; Fanger GR; Woda BA; Banner BF; Algate P; Dresser K; Xu J; Chu PG
Hum Pathol; 2003 Aug; 34(8):792-6. PubMed ID: 14506641
[TBL] [Abstract][Full Text] [Related]
9. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.
Jiang Z; Wu CL; Woda BA; Dresser K; Xu J; Fanger GR; Yang XJ
Am J Surg Pathol; 2002 Sep; 26(9):1169-74. PubMed ID: 12218573
[TBL] [Abstract][Full Text] [Related]
10. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Paner GP; Luthringer DJ; Amin MB
Arch Pathol Lab Med; 2008 Sep; 132(9):1388-96. PubMed ID: 18788849
[TBL] [Abstract][Full Text] [Related]
11. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas.
Lin F; Brown RE; Shen T; Yang XJ; Schuerch C
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):153-9. PubMed ID: 15354742
[TBL] [Abstract][Full Text] [Related]
13. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Rubin MA; Bismar TA; Andrén O; Mucci L; Kim R; Shen R; Ghosh D; Wei JT; Chinnaiyan AM; Adami HO; Kantoff PW; Johansson JE
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1424-32. PubMed ID: 15941951
[TBL] [Abstract][Full Text] [Related]
14. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
[TBL] [Abstract][Full Text] [Related]
15. A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissue.
Mills AM; Guo FP; Copland AP; Pai RK; Pinsky BA
Am J Surg Pathol; 2013 Jul; 37(7):995-1000. PubMed ID: 23648457
[TBL] [Abstract][Full Text] [Related]
16. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study.
Ng VW; Koh M; Tan SY; Tan PH
Am J Clin Pathol; 2007 Feb; 127(2):248-53. PubMed ID: 17210521
[TBL] [Abstract][Full Text] [Related]
17. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
Nassar A; Amin MB; Sexton DG; Cohen C
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251
[TBL] [Abstract][Full Text] [Related]
18. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.
Zhou M; Chinnaiyan AM; Kleer CG; Lucas PC; Rubin MA
Am J Surg Pathol; 2002 Jul; 26(7):926-31. PubMed ID: 12131161
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer.
Wang J; Wei J; Pu T; Zeng A; Karthikeyan V; Bechtold B; Vo K; Chen J; Lin TP; Chang AP; Corey E; Puhr M; Klocker H; Culig Z; Bland T; Wu BJ
Cell Rep Med; 2024 Feb; 5(2):101388. PubMed ID: 38262412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
